Skip to content

Improving Sleep and Quality of Life in Adults With HIV Disease

Improving Sleep and Quality of Life in Adults With HIV Disease: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01073423
Acronym
R&R
Enrollment
20
Registered
2010-02-23
Start date
2010-01-31
Completion date
2010-04-30
Last updated
2010-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

HIV, sleep, insomnia, yoga, music

Brief summary

The purpose of this study is to see if yoga or music therapy can improve the sleep of adults with HIV.

Interventions

BEHAVIORALMusic Therapy

1-hour music therapy sessions, administered in group format 3 times per week for 8 weeks.

BEHAVIORALYoga

1-hour yoga sessions administered in group format 3 times per week for 8 weeks

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* at least 18 years of age * HIV seropositive * current sleep disturbance * able to speak, read, and write in English * a phone number to maintain contact with research team * willing to provide copy of most recent CD4 and viral load values * willing to wear actigraph for 1 week per month for 3 months * willing to participate in group intervention sessions 3 times per week for 8 weeks

Exclusion criteria

* pregnancy * psychiatric diagnosis, such as schizophrenia, dementia, bipolar disorder (depression not excluded) * sleep disorder diagnosis, such as apnea or narcolepsy (insomnia not excluded) * current yoga practice

Design outcomes

Primary

MeasureTime frame
self-reported sleep disturbance8 weeks

Secondary

MeasureTime frame
actigraphic estimates of sleep quality and quantity8 weeks
self-reported well-being8 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026